GL1X · GenesisL1 explorer

MolNFT v1 · #143519 · protein

Crystal structure oxa-24 beta-lactamase complexed with wck 4234 by co- crystallization

6B22: “Crystal structure oxa-24 beta-lactamase complexed with wck 4234 by co- crystallization”. X-ray diffraction, 2 ligands (C8Y, CL), 1 pocket (best druggability 0.49). MolNFT v1 #143519 on GenesisL1: 3D structure, binding sites and…

PDB
6B22
Type
protein
Length
244 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
UniProt
Q8RLA6
Ligands
C8Y, CL
Pockets
1 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamaseprotein24442% helix, 21% strandQ8RLA6

Ligands and binding sites

  • C8Y · (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carbonitrile · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12180.490.7530C8Y

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6B22 · Crystal structure OXA-24 beta-lactamase complexed with WCK 4234 by co-crystallization · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.